技術・イノベーションマネジメント

Managing clinical trials during COVID-19 and beyond

A new, groundbreaking predictive analytical approach which can be deployed in a few weeks to cope with the current crisis, and has the broader potential to transform clinical operations.

Legacy transformation dilemma

How to minimize risks and accelerate returns

2 x
Average expected increase in revenue contribution from breakthrough innovations 5 years from now
66 %
Companies that recognize a need and ambition to improve their overall innovation performance
30 %
Shorter time-to-break-even for new products that top innovation performers enjoy compared to the average company
経営課題
提供サービス
主な実績